Murine psoriasis-like disorder induced by naive CD4+ T cells
- 1 February 1997
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (2) , 183-188
- https://doi.org/10.1038/nm0297-183
Abstract
Psoriasis is a complex disorder involving alterations of many cell types. Although evidence suggests a T-cell pathogenesis for psoriasis, a primary role of T cells has not been directly demonstrated. Here, we show that reconstitution of scid/scid mice with minor histocompatibility mismatched naive CD4+ T lymphocytes resulted in skin alterations that strikingly resembled human psoriasis clinically, histopathologically and in cytokine expression. This skin disorder was diminished when memory T cells were coinjected. Thus, a subset of dysregulated CD4+ T cells can cause tissue alterations seen in psoriasis without the presence of CD8+ cells or a primary epithelial abnormality.Keywords
This publication has 40 references indexed in Scilit:
- Molecular and functional aspects of PECAM-1/CD31Published by Elsevier ,2003
- Increased Epidermal Growth Factor Receptor in fsn/fsn MiceJournal of Investigative Dermatology, 1996
- CD4 antibody treatment of severe psoriasisThe Lancet, 1991
- Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasisThe Lancet, 1991
- Inherited Mouse Mutations as Models of Human Adnexal, Cornification, and Papulosquamous DermatosesJournal of Investigative Dermatology, 1990
- The Role of Adhesion Molecules, Chemotactic Factors, and Cytokines in Inflammatory and Neoplastic Skin Disease—1990 UpdateJournal of Investigative Dermatology, 1990
- Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.The Journal of Experimental Medicine, 1987
- Two keratins MW 50,000 and 56,000 are synthesized by psoriatic epidermisBritish Journal of Dermatology, 1984
- H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors.The Journal of Experimental Medicine, 1984
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979